References
- Kligman AM. Ocular rosacea: current concepts and therapy. (Editorial) Arch Dermatol 1997; 133(1): 89–90
- Berg M, Liden S. An epidemiological study of rosacea. Acta Derm Venereol 1989; 69(5): 419–23
- Browning DJ, Rosenwasser G, Lugo M. Ocular rosacea in blacks. Am J Ophthalmol 1986; 101(4): 441–4
- Sibenge S, Gawkrodger DJ. Rosacea: a study of clinical patterns, blood flow, and the role of Demodex folliculorum. J Am Acad Dermatol 1992; 26(4): 590–3
- Drolet B, Palier AS. Childhood rosacea. Pediatr Dermatol 1992; 9(1): 22–6
- Thiboutot DM. Acne rosacea. Am Fam Physician 1994; 50(8): 1691–7, 1701–2
- Bonnar E, Eustace P, Powell FC. The Demodex mite population in rosacea. J Am Acad Dermatol 1993; 28(3): 443–8
- Dahl M, ed. Rosacea: diagnosis and treatment. In: Perspectives. Minnetonka, Minn: Mark Dahl & Associates, 1996
- Browning DJ, Proia AD. Ocular rosacea. Surv Ophthalmol 1986; 31 (3): 145–58
- Aronson IK, Rumsfield JA, West DP, et al. Evaluation of topical metronidazole gel in acne rosacea. Drug Intell Clin Pharm 1987; 21(4): 346–51
- Dahl MV, Katz HI, Krueger GG, et al. Topical metronidazole maintains remissions of rosacea. Poster presented at: American Academy of Dermatology; March 21–26
- James W, Dahi M, Sober A, et al. Psychological impact of rosacea may be more severe than physical condition. Cosmetic Dermatol 1997; 10: 27–30
- Wilkin JK. Vasodilator rosacea. Arch Dermatol 1980; 116(5): 598
- Gilleaudeau P, Vallat VP, Carter DM, et al. Angiotensin-converting enzyme inhibitors as possible exacerbating drugs in psoriasis. J Am Acad Dermatol 1993; 28(3): 490–2
- Litt JZ, Pawlak WA Jr. Drug eruption reference manual. New York: Parthenon Publishing, 1997
- Berg M, Liden S. Postmenopausal female rosacea patients are more disposed to react with migraine. (Letter) Dermatology 1996; 193(1): 73–4